Related content

8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer

By Verwaal Vic  

Annals of Surgical Oncology, Vol. 15, Iss. 9, 2008-09 ,pp. : 2426-2432

Springer Publishing Company

Access to resources Recommend Favorite

Costs and clinical outcome of neoadjuvant systemic chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from gastric cancer

By Hultman Bo   Lundkvist Jonas   Glimelius Bengt   Nygren Peter   Mahteme Haile  

Acta Oncologica, Vol. 51, Iss. 1, 2012-01 ,pp. : 112-121

Informa Healthcare

Access to resources Recommend Favorite

Impact of the Peritoneal Surface Disease Severity Score on Survival in Patients with Colorectal Cancer Peritoneal Carcinomatosis Undergoing Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy

By Chua Terence  

Annals of Surgical Oncology, Vol. 17, Iss. 5, 2010-05 ,pp. : 1330-1336

Springer Publishing Company

Access to resources Recommend Favorite

Failure Analysis of Recurrent Disease Following Complete Cytoreduction and Perioperative Intraperitoneal Chemotherapy in Patients with Peritoneal Carcinomatosis from Colorectal Cancer

By Bijelic Lana   Yan Tristan   Sugarbaker Paul  

Annals of Surgical Oncology, Vol. 14, Iss. 8, 2007-08 ,pp. : 2281-2288

Springer Publishing Company

Access to resources Recommend Favorite

Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin

By Witkamp A.J.   de Bree E.   Kaag M.M.   Boot H.   Beijnen J.H.   van Slooten G.W.   van Coevorden F.   Zoetmulder F.A.N.  

European Journal of Cancer, Vol. 37, Iss. 8, 2001-05 ,pp. : 979-984

Elsevier

Access to resources Recommend Favorite